Viewing Study NCT01386827



Ignite Creation Date: 2024-05-05 @ 11:39 PM
Last Modification Date: 2024-10-26 @ 10:37 AM
Study NCT ID: NCT01386827
Status: COMPLETED
Last Update Posted: 2011-10-28
First Post: 2011-06-30

Brief Title: Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis
Sponsor: Helsinki University Central Hospital
Organization: Helsinki University Central Hospital

Study Overview

Official Title: Ability of the New Vero-cell-derived Inactivated Japanese Encephalitis Vaccine IXIARO to Elicit a Booster Response in Travellers Previously Vaccinated With Traditional Mouse-brain Derived Vaccine JE-MB
Status: COMPLETED
Status Verified Date: 2011-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The old mouse brain derived Japanese encephalitis vaccines MBJEV have been reported to cause serious adverse effects and are therefore replaced with the novel Ixiaro vaccine The present study investigates whether vaccinees primed with MBJEV can be boosted with Ixiaro

Travellers receiving Japanese encephalitis vaccines are enrolled for a follow-up of immune responses in four groups A primary immunization with BMJEV B primary and secondary immunizations with MBJEV C primary immunizations with Ixiaro and S Primary immunization with MBJEV and secondary immunization with Ixiaro Immune responses are followed with help of serum samples collected before and after vaccination
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None